Transient gene transfer and expression of Smad7 prevents bleomycin- induced lung fibrosis in mice

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 5-11

  Nakao, Atsuhito ^a,b   Fujii, Makiko ^c   Matsumura, Ryutaro ^d   Kumano, Kotaro ^a   Saito, Yasushi ^a   Miyazono, Kohei ^c   Iwamoto, Itsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c CANCER INSTITUTE   (Japan)

^d TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; MESSENGER RNA; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032719815     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6094     Document Type: Article

References (37)

1. Border, W.A., and Noble, N.A. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 10:1286-1292.
2. Broekelmann, T.J., Limper, A.H., Colby, T.V., and McDonald, J.A. 1991. Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 88:6642-6646.
3. Deguchi, Y. 1992. Spontaneous increase of transforming growth factor-β production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung. Ann. Rheum. Dis. 51:362-365.
4. Khalil, N., Bereznay, O., Sporn, M., and Greenberg, A. 1989. Macrophage production of transforming growth factor-β and fibroblast collagen synthes is in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
5. Khalil, N., Whitman, C., Zuo, L., Danelpour, D., and Greenberg, A. 1993. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in rats. J. Clin. Invest. 92:1812-1818.
6. Westergren-Thorsson, G., et al. 1993. Altered expression of small proteoglycans, collagen, and transforming growth factor-β in developing blecmycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:632-637.
7. Zhang, K., Flanders, K.C., and Phan, S.H. 1995. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:352-361.
8. Giri, S.N., Hyde, D.M., and Hollinge, M.A. 1993. Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax. 48:959-966.
9. Massagué, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753-791.
10. Heldin, C.-H., Miyazono, K., and ten Dijke, P. 1997. TGF-β signalling from the membrane to the nucleus through SMAD proteins. Nature. 390 465-473.
11. Nakao, A., et al. 1997. TGF-β receptor mediated signalling through Smad2, Smad3, and Smad4. EMBO J. 16:5353-5362.
12. Macias-Silva, M., et al. 1996. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 87:1215-1224.
13. Nakao, A., et al. 1997. Identification of Smad7, a TGF - inducible antagonist of TGF-β signalling. Nature. 389:631-635.
14. Hayashi, H., et al. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell. 89:1165-1173.
15. Topper, J.N., et al. 1997. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA. 94:9314-9319.
16. Niwa, H., Yamamura, K., and Miyazaki, J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:193-200.
17. Saito, I., Oya, Y., Yamamoto, K., Yuasa, T., and Shimojo, H. 1985. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54:711-719.
18. Miyake, S., et al. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad Sci. USA. 93:1320-1324.
19. Yaekashiwa, M., et al. 1997. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphological study. Am. J. Respir. Crit. Care Med. 156:1937-1944.
20. Lan Tran, P., et al. 1997. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J. Clin. Invest. 99:608-617.
21. Kutoda, K., and Shinkai, H. 1997. Gene expression of type I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch. Dermatol. Res. 289:567-572.
22. Persson, U., et al. 1998. The L45 loop in type I receptors for TGF-β family member is a critical determinant in specifying Smad isoform activation. FEBS Lett. 434:83-87.
23. Woessner, J.F., Jr. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93:440-447.
24. Green, G.D., and Reagan, K. 1992. Determination of hydroxyproline by high pressure liquid chromatography. Anal. Biochem. 201:265-269.
25. Iwamoto, I., Kumano, K., Kasai, M., Kurasawa, K., and Nakao, A. 1996. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am. J. Respir. Crit. Care Med. 154:1257-1260.
26. Nakajima, H., Sano, H., Nishimura, T., Yoshida, S., and Iwamoto, I. 1994. Role of VCAM-1/VLA-4 and ICAM-1/LFA-1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1145-1154.
27. Brody, S.L., and Crystal, R.G. 1994. Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716:90-101.
28. Itoh, S., et al. 1998. Transforming growth factor-β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:29195-29201.
29. Casellas, R., and Hammalti-Brivanlou, A. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. 1998. Dev. Biol. 198:1-12.
30. Imamura, T., et al. 1997. Smad6 inhibits signalling by the TGF-β super-family. Nature. 389:622-626.
31. Hata, A., Lagna, G., Massague, M., and Hemmalti-Brivanlou, A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:186-197.
32. Vindevoghel, L., et al. 1998. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β. J. Biol. Chem. 273:13053-13057.
33. Chen, S.J., et al. 1999. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β. J. Invest. Dermatol. 112:49-57.
34. Sime, P.J., et al. 1998. Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of TGF-β1 and myofibroblasts. Am. J. Pathol. 153:825-832.
35. Kelley, J. 1990. Cytokines of the lung. Am. Rev. Respir. Dis. 141:765-768.
36. Piguet, P.F., et al. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
37. Boucher, R.C. 1999. Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103:441-445.